期刊
JOURNAL OF VIROLOGICAL METHODS
卷 132, 期 1-2, 页码 85-91出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jviromet.2005.09.002
关键词
prion protein; CJD; spleen; brain tonsil; DELFIA; immunoassay
Concern about the possible secondary spread of variant Creutzfeldt-Jakob disease (vCJD) through blood transfusion and blood products has increased the need for a sensitive and rapid test for the identification of PrPSc in specimens collected non-invasively from living persons. Furthermore, an accurate estimate of the prevalence of pre-clinical vCJD in the British population Would be possible if there were such a test that could be applied to specimens available readily (e.g. blood and urine). As a first step towards that goal, we have developed a simple and sensitive test for the detection of PrPSc in peripheral tissues and brain of vCJD patients, based on the differential extraction of PrPSc with guanidine hydrochloride. The prion protein (PrP) isoforms are extracted sequentially from homogenized tissue by applying two different concentrations of this chaotropic agent. Each extraction yields a fraction of the PrP isoforms with different solubilities in guanidine hydrochloride. Quantitation of the two fractions (relatively insoluble or relatively soluble) using time resolved fluorescence (DELFIA) as a reporter system allows differentiation between PrPSc infected and non-infected tissues. The assay has a detection limit of 10 pg PrP, is robust and could be automated. (c) 2005 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据